title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday,20220725T083855,https://www.benzinga.com/news/22/07/28182325/this-technology-stock-surged-235-here-are-77-biggest-movers-from-friday,AMN,0.057559,Neutral,0.0
Stocks That Hit 52-Week Lows On Monday,20220516T175917,https://www.benzinga.com/markets/options/22/05/27226401/52-weeks-high-and-low-article,AMN,0.026147,Somewhat-Bearish,-0.22125
McKesson  ( MCK )  Announces Availability of FDA-Cleared Drug for MCL,20230215T140500,https://www.zacks.com/stock/news/2054602/mckesson-mck-announces-availability-of-fda-cleared-drug-for-mcl,AMN,0.224903,Neutral,-0.055264
"Medical Products Stocks' Earnings Due on Feb 15: WST, ITGR & More",20240214T135600,https://www.zacks.com/stock/news/2226041/medical-products-stocks-earnings-due-on-feb-15-wst-itgr-more,AMN,0.303175,Somewhat-Bullish,0.315302
"Medical Device Stocks' Q4 Earnings on Feb 16: WST, SWAV & More",20230215T143300,https://www.zacks.com/stock/news/2054626/medical-device-stocks-q4-earnings-on-feb-16-wst-swav-more,AMN,0.284621,Neutral,0.083483
PacBio's  ( PACB )  Preliminary Q4 Revenues Dampened by Lower Sales,20230112T172900,https://www.zacks.com/stock/news/2038656/pacbios-pacb-preliminary-q4-revenues-dampened-by-lower-sales,AMN,0.210274,Neutral,0.006514
Here's Why You Should Retain PacBio  ( PACB )  Stock for Now,20230104T173400,https://www.zacks.com/stock/news/2035314/heres-why-you-should-retain-pacbio-pacb-stock-for-now,AMN,0.214462,Neutral,-0.05154
"PacBio's  ( PACB )  Q3 Earnings Top Estimates, Revenues Lag",20221108T150000,https://www.zacks.com/stock/news/2015503/pacbios-pacb-q3-earnings-top-estimates-revenues-lag,AMN,0.163078,Neutral,0.065329
PacBio's  ( PACB )  New Method for TR Profiling Now Available,20220928T170800,https://www.zacks.com/stock/news/1986188/pacbios-pacb-new-method-for-tr-profiling-now-available,AMN,0.230235,Somewhat-Bullish,0.196733
3 Reasons to Retain PacBio  ( PACB )  Stock in Your Portfolio,20220921T120200,https://www.zacks.com/stock/news/1983014/3-reasons-to-retain-pacbio-pacb-stock-in-your-portfolio,AMN,0.215894,Somewhat-Bullish,0.187192
PacBio  ( PACB )  Supports SickKids With Sequencing Technology,20220307T155700,https://www.zacks.com/stock/news/1878533/pacbio-pacb-supports-sickkids-with-sequencing-technology,AMN,0.245649,Neutral,0.038247
